China Grand Pharmaceutical and Healthcare Holdings Ltd (HKG: 0512; CGP) has announced its intention to acquire a 63% stake in Chongqing Duoputai Pharmaceutical Co., Ltd for RMB 442 million (approximately USD 62 million).
This acquisition will elevate CGP Pharma’s ownership in Duoputai to 90%, granting the company full control over the latter’s anticoagulant portfolio. This strategic move underscores CGP’s commitment to expanding its presence in the pharmaceutical sector.- Flcube.com
